Description

The HOYA Vivinex iSert XC1 CLEAR is a state-of-the-art monofocal intraocular lens (IOL) meticulously crafted for use in cataract surgery. Engineered by HOYA, this lens is preloaded for ease of implantation, enhancing surgical efficiency and precision.

Advanced Material

Constructed from glistening-free hydrophobic acrylic, known as Vivinex™, the lens includes a UV filter to protect ocular health. This innovative material choice ensures long-term clarity and reduces visual disturbances, providing patients with consistently clear vision.

Optic Design

The lens features a sophisticated aspheric optic design, which:

• Compensates for corneal spherical aberration
• Enhances image quality
• Increases tolerance to optical imperfections such as coma

The optic edge is square, thin, and textured, significantly minimizing the risk of posterior capsule opacification (PCO) and maintaining visual clarity over time.

Surface and Haptic Design

The lens undergoes active oxygen processing, resulting in an exceptionally smooth surface. The sharp, textured optic edge further reduces PCO. The haptic design includes a textured-rough surface, ensuring stable positioning within the eye.

Dimensions and Power Range

• Optic Diameter: 6.00 mm
• Overall Length: 13.00 mm
• Power Range: +6.00 to +30.00 diopters, available in 0.50 D increments

These specifications allow for precise customization to meet individual patient needs.

Injector System

The Vivinex iSert system, also known as the multiSert™ system, provides a preloaded injector with stepwise instructions, facilitating seamless implantation. The front injector tip has an outer diameter of 1.70 mm, and the recommended incision size is 2.20 mm, making it ideal for micro-incision cataract surgery (MICS).

Intended Use

Designed for healthcare professionals, this IOL aims to deliver consistent visual outcomes, enhance biocompatibility, and maintain long-term transparency. Laboratory and clinical data underscore its low incidence of PCO and enduring clarity.

For comprehensive indications and contraindications, practitioners are advised to consult the Instructions For Use, ensuring optimal application and patient outcomes.